Treatment And Inhibition Of Inflammatory Lung Diseases In Patients Having Risk Alleles In The Genes Encoding Il33 And Il1Rl1 - EP3957752

The patent EP3957752 was granted to Regeneron Pharmaceuticals on Aug 20, 2025. The application was originally filed on Mar 20, 2018. The patent is currently recorded with a legal status of "Granted".

EP3957752

REGENERON PHARMACEUTICALS
Filing Date
Mar 20, 2018
Status
Granted
Grant Date
Aug 20, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Get instant alerts for new documents